# Translating Molecular Insights into Effective Targeting of Glioblastoma Stem Cells

## TL;DR

This paper reviews how glioblastoma stem cells adapt dynamically and how targeting their survival mechanisms could improve treatment outcomes.

## Contribution

The paper integrates molecular and microenvironmental insights to propose combinatorial therapeutic strategies for glioblastoma stem cells.

## Key findings

- Glioblastoma stem cells exhibit plasticity through genetic, epigenetic, and metabolic adaptations.
- Standard therapies like TMZ and radiation can promote glioblastoma stem cell resilience and recurrence.
- Combinatorial targeting of stemness, metabolism, epigenetics, and immune evasion is suggested for effective treatment.

## Abstract

Glioblastoma stem cells (GSCs) play a central role in glioblastoma initiation, heterogeneity, therapeutic resistance, and recurrence. Rather than representing a fixed population, GSCs exhibit dynamic and reversible cellular states shaped by genetic and epigenetic programs and by signals from hypoxic, vascular, and immune niches. Advances in single-cell and spatial profiling have revealed extensive GSC plasticity, including transitions between proliferative and quiescent states and between proneural and mesenchymal phenotypes. These adaptive programs are reinforced by metabolic flexibility, immune suppression, and regulatory networks controlled by non-coding RNAs. Importantly, standard therapies can inadvertently promote GSC-associated survival mechanisms, contributing to treatment failure. This review integrates current insights into the molecular and microenvironmental circuits that sustain GSC identity and resilience, and discusses emerging therapeutic strategies aimed at disrupting these networks through combinatorial targeting of stemness, metabolism, epigenetic regulation, and immune evasion to enable more durable glioblastoma control.

Glioblastoma stem cells (GSCs) function as dynamic regulators of tumor persistence, maintained by interconnected genetic, epigenetic, metabolic, and microenvironment-derived circuits. Rather than fixed entities, GSCs continuously recalibrate their functional state as transcriptional regulators, chromatin architecture, and non-coding RNA networks shift in response to microenvironmental cues. Hypoxic, vascular, and immune niches reinforce these adaptive states by stabilizing HIF signaling, modulating cytokine gradients, and sustaining immunosuppression. Metabolic flexibility further supports survival under therapeutic and environmental stress. Standard therapies inadvertently activate these same resilience pathways: TMZ enhances DNA repair and quiescent survival, while radiation promotes mesenchymal transition and immune evasion, thereby enriching GSC-associated circuits that drive recurrence. Understanding how these molecular circuits converge to sustain stemness, plasticity, and microenvironmental crosstalk highlights the need for combinatorial strategies that simultaneously disrupt epigenetic gating, metabolic rewiring, ncRNA-controlled repair, and niche-dependent signaling to achieve durable glioblastoma control.